Cargando…

(−)-Epicatechin-3-O-β-d-allopyranoside from Davallia formosana, Prevents Diabetes and Hyperlipidemia by Regulation of Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice

The purpose of this experiment was to determine the antidiabetic and lipid-lowering effects of (−)-epicatechin-3-O-β-d-allopyranoside (BB) from the roots and stems of Davallia formosana in mice. Animal treatment was induced by high-fat diet (HFD) or low-fat diet (control diet, CD). After eight weeks...

Descripción completa

Detalles Bibliográficos
Autores principales: Shih, Chun-Ching, Wu, Jin-Bin, Jian, Jia-Ying, Lin, Cheng-Hsiu, Ho, Hui-Ya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632785/
https://www.ncbi.nlm.nih.gov/pubmed/26492243
http://dx.doi.org/10.3390/ijms161024983
_version_ 1782399096064049152
author Shih, Chun-Ching
Wu, Jin-Bin
Jian, Jia-Ying
Lin, Cheng-Hsiu
Ho, Hui-Ya
author_facet Shih, Chun-Ching
Wu, Jin-Bin
Jian, Jia-Ying
Lin, Cheng-Hsiu
Ho, Hui-Ya
author_sort Shih, Chun-Ching
collection PubMed
description The purpose of this experiment was to determine the antidiabetic and lipid-lowering effects of (−)-epicatechin-3-O-β-d-allopyranoside (BB) from the roots and stems of Davallia formosana in mice. Animal treatment was induced by high-fat diet (HFD) or low-fat diet (control diet, CD). After eight weeks of HFD or CD exposure, the HFD mice were treating with BB or rosiglitazone (Rosi) or fenofibrate (Feno) or water through gavage for another four weeks. However, at 12 weeks, the HFD-fed group had enhanced blood levels of glucose, triglyceride (TG), and insulin. BB treatment significantly decreased blood glucose, TG, and insulin levels. Moreover, visceral fat weights were enhanced in HFD-fed mice, accompanied by increased blood leptin concentrations and decreased adiponectin levels, which were reversed by treatment with BB. Muscular membrane protein levels of glucose transporter 4 (GLUT4) were reduced in HFD-fed mice and significantly enhanced upon administration of BB, Rosi, and Feno. Moreover, BB treatment markedly increased hepatic and skeletal muscular expression levels of phosphorylation of AMP-activated (adenosine monophosphate) protein kinase (phospho-AMPK). BB also decreased hepatic mRNA levels of phosphenolpyruvate carboxykinase (PEPCK), which are associated with a decrease in hepatic glucose production. BB-exerted hypotriglyceridemic activity may be partly associated with increased mRNA levels of peroxisome proliferator activated receptor α (PPARα), and with reduced hepatic glycerol-3-phosphate acyltransferase (GPAT) mRNA levels in the liver, which decreased triacylglycerol synthesis. Nevertheless, we demonstrated BB was a useful approach for the management of type 2 diabetes and dyslipidemia in this animal model.
format Online
Article
Text
id pubmed-4632785
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-46327852015-11-23 (−)-Epicatechin-3-O-β-d-allopyranoside from Davallia formosana, Prevents Diabetes and Hyperlipidemia by Regulation of Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice Shih, Chun-Ching Wu, Jin-Bin Jian, Jia-Ying Lin, Cheng-Hsiu Ho, Hui-Ya Int J Mol Sci Article The purpose of this experiment was to determine the antidiabetic and lipid-lowering effects of (−)-epicatechin-3-O-β-d-allopyranoside (BB) from the roots and stems of Davallia formosana in mice. Animal treatment was induced by high-fat diet (HFD) or low-fat diet (control diet, CD). After eight weeks of HFD or CD exposure, the HFD mice were treating with BB or rosiglitazone (Rosi) or fenofibrate (Feno) or water through gavage for another four weeks. However, at 12 weeks, the HFD-fed group had enhanced blood levels of glucose, triglyceride (TG), and insulin. BB treatment significantly decreased blood glucose, TG, and insulin levels. Moreover, visceral fat weights were enhanced in HFD-fed mice, accompanied by increased blood leptin concentrations and decreased adiponectin levels, which were reversed by treatment with BB. Muscular membrane protein levels of glucose transporter 4 (GLUT4) were reduced in HFD-fed mice and significantly enhanced upon administration of BB, Rosi, and Feno. Moreover, BB treatment markedly increased hepatic and skeletal muscular expression levels of phosphorylation of AMP-activated (adenosine monophosphate) protein kinase (phospho-AMPK). BB also decreased hepatic mRNA levels of phosphenolpyruvate carboxykinase (PEPCK), which are associated with a decrease in hepatic glucose production. BB-exerted hypotriglyceridemic activity may be partly associated with increased mRNA levels of peroxisome proliferator activated receptor α (PPARα), and with reduced hepatic glycerol-3-phosphate acyltransferase (GPAT) mRNA levels in the liver, which decreased triacylglycerol synthesis. Nevertheless, we demonstrated BB was a useful approach for the management of type 2 diabetes and dyslipidemia in this animal model. MDPI 2015-10-20 /pmc/articles/PMC4632785/ /pubmed/26492243 http://dx.doi.org/10.3390/ijms161024983 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Shih, Chun-Ching
Wu, Jin-Bin
Jian, Jia-Ying
Lin, Cheng-Hsiu
Ho, Hui-Ya
(−)-Epicatechin-3-O-β-d-allopyranoside from Davallia formosana, Prevents Diabetes and Hyperlipidemia by Regulation of Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice
title (−)-Epicatechin-3-O-β-d-allopyranoside from Davallia formosana, Prevents Diabetes and Hyperlipidemia by Regulation of Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice
title_full (−)-Epicatechin-3-O-β-d-allopyranoside from Davallia formosana, Prevents Diabetes and Hyperlipidemia by Regulation of Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice
title_fullStr (−)-Epicatechin-3-O-β-d-allopyranoside from Davallia formosana, Prevents Diabetes and Hyperlipidemia by Regulation of Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice
title_full_unstemmed (−)-Epicatechin-3-O-β-d-allopyranoside from Davallia formosana, Prevents Diabetes and Hyperlipidemia by Regulation of Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice
title_short (−)-Epicatechin-3-O-β-d-allopyranoside from Davallia formosana, Prevents Diabetes and Hyperlipidemia by Regulation of Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice
title_sort (−)-epicatechin-3-o-β-d-allopyranoside from davallia formosana, prevents diabetes and hyperlipidemia by regulation of glucose transporter 4 and amp-activated protein kinase phosphorylation in high-fat-fed mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632785/
https://www.ncbi.nlm.nih.gov/pubmed/26492243
http://dx.doi.org/10.3390/ijms161024983
work_keys_str_mv AT shihchunching epicatechin3obdallopyranosidefromdavalliaformosanapreventsdiabetesandhyperlipidemiabyregulationofglucosetransporter4andampactivatedproteinkinasephosphorylationinhighfatfedmice
AT wujinbin epicatechin3obdallopyranosidefromdavalliaformosanapreventsdiabetesandhyperlipidemiabyregulationofglucosetransporter4andampactivatedproteinkinasephosphorylationinhighfatfedmice
AT jianjiaying epicatechin3obdallopyranosidefromdavalliaformosanapreventsdiabetesandhyperlipidemiabyregulationofglucosetransporter4andampactivatedproteinkinasephosphorylationinhighfatfedmice
AT linchenghsiu epicatechin3obdallopyranosidefromdavalliaformosanapreventsdiabetesandhyperlipidemiabyregulationofglucosetransporter4andampactivatedproteinkinasephosphorylationinhighfatfedmice
AT hohuiya epicatechin3obdallopyranosidefromdavalliaformosanapreventsdiabetesandhyperlipidemiabyregulationofglucosetransporter4andampactivatedproteinkinasephosphorylationinhighfatfedmice